2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]oxazolo[5,4-b]pyridine;2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]thiazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]thiazolo[5,4-b]pyridine;3-phenyl-2-[2,4,6-trimethyl-3,5-bis(3-phenylimidazo[4,5-b]pyrazin-2-yl)phenyl]imidazo[4,5-b]pyrazine
C150H126N24O3S3 — CID 158850391
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]oxazolo[5,4-b]pyridine;2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]thiazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]thiazolo[5,4-b]pyridine;3-phenyl-2-[2,4,6-trimethyl-3,5-bis(3-phenylimidazo[4,5-b]pyrazin-2-yl)phenyl]imidazo[4,5-b]pyrazine
2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]oxazolo[5,4-b]pyridine;2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]thiazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]thiazolo[5,4-b]pyridine;3-phenyl-2-[2,4,6-trimethyl-3,5-bis(3-phenylimidazo[4,5-b]pyrazin-2-yl)phenyl]imidazo[4,5-b]pyrazine (PubChem CID 158850391) has the molecular formula C150H126N24O3S3 and a molecular weight of 2409.02 g/mol. Its IUPAC name is 2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]oxazolo[5,4-b]pyridine;2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]thiazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]thiazolo[5,4-b]pyridine;3-phenyl-2-[2,4,6-trimethyl-3,5-bis(3-phenylimidazo[4,5-b]pyrazin-2-yl)phenyl]imidazo[4,5-b]pyrazine.
Molecular Properties
| Compound Name | 2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]oxazolo[5,4-b]pyridine;2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]thiazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]thiazolo[5,4-b]pyridine;3-phenyl-2-[2,4,6-trimethyl-3,5-bis(3-phenylimidazo[4,5-b]pyrazin-2-yl)phenyl]imidazo[4,5-b]pyrazine |
|---|---|
| PubChem CID | 158850391 |
| Molecular Formula | C150H126N24O3S3 |
| Molecular Weight | 2409.02 g/mol |
| Exact Mass | 2406.96 |
| IUPAC Name | 2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]oxazolo[5,4-b]pyridine;2-[4-[3,5-bis[2,3,5,6-tetramethyl-4-([1,3]thiazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-2,3,5,6-tetramethylphenyl]-[1,3]thiazolo[5,4-b]pyridine;3-phenyl-2-[2,4,6-trimethyl-3,5-bis(3-phenylimidazo[4,5-b]pyrazin-2-yl)phenyl]imidazo[4,5-b]pyrazine |
| SMILES | Cc1c(-c2nc3nccnc3n2-c2ccccc2)c(C)c(-c2nc3nccnc3n2-c2ccccc2)c(C)c1-c1nc2nccnc2n1-c1ccccc1.Cc1c(C)c(-c2nc3cccnc3o2)c(C)c(C)c1-c1cc(-c2c(C)c(C)c(-c3nc4cccnc4o3)c(C)c2C)cc(-c2c(C)c(C)c(-c3nc4cccnc4o3)c(C)c2C)c1.Cc1c(C)c(-c2nc3cccnc3s2)c(C)c(C)c1-c1cc(-c2c(C)c(C)c(-c3nc4cccnc4s3)c(C)c2C)cc(-c2c(C)c(C)c(-c3nc4cccnc4s3)c(C)c2C)c1 |
| InChI | InChI=1S/C54H48N6O3.C54H48N6S3.C42H30N12/c2*1-25-31(7)46(52-58-40-16-13-19-55-49(40)61-52)32(8)26(2)43(25)37-22-38(44-27(3)33(9)47(34(10)28(44)4)53-59-41-17-14-20-56-50(41)62-53)24-39(23-37)45-29(5)35(11)48(36(12)30(45)6)54-60-42-18-15-21-57-51(42)63-54;1-25-31(37-49-34-40(46-22-19-43-34)52(37)28-13-7-4-8-14-28)26(2)33(39-51-36-42(48-24-21-45-36)54(39)30-17-11-6-12-18-30)27(3)32(25)38-50-35-41(47-23-20-44-35)53(38)29-15-9-5-10-16-29/h2*13-24H,1-12H3;4-24H,1-3H3 |
| InChIKey | IZJJSICYBPDXDU-UHFFFAOYSA-N |
| XLogP | 37.40 |
| TPSA | 324.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 180 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2409.02 |
| LogP ≤ 5 | 37.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 30 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158850391 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.